Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Tandem Diabetes Care Inc (TNDM)

Healthcare Medical Devices
19.50 $
+2.6% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Tandem Diabetes Care Inc (TNDM)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.8% of the shares are freely tradable; institutional investors hold 117.8%.

Ownership Structure

Institutional ownership
117.8%
Insiders
1.0%
Float
91.8%
Short % of float
21.3%
Shares Outstanding
69Mio.

Largest Shareholders

Institutions

Institutions TNDM
Name Stake (%) Shares Change (%) Date
BlackRock Inc 15.60 10,690,844 -4.1 03/31/2026
Vanguard Group Inc 10.71 7,341,356 +3.9 12/31/2025
Sessa Capital, L.P 6.90 4,730,757 -5.4 03/31/2026
Vanguard Portfolio Management, LLC 5.83 3,993,333 +0.0 03/31/2026
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 4.53 3,103,609 +7.4 03/31/2026
Vanguard Capital Management, LLC 4.43 3,038,919 +0.0 03/31/2026
GW&K Investment Management, LLC 3.92 2,689,106 +0.5 03/31/2026
State Street Corp 3.88 2,662,260 +0.8 03/31/2026
Driehaus Capital Management LLC 3.36 2,304,414 +43.1 03/31/2026

Funds

Funds TNDM
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.00 4,111,772 +0.0 05/29/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
15. Jul 2026 Kyrillos Jean-Claude EVP & Chief Operating Officer Other 1,926 15.28 29,429
15. Jul 2026 Kyrillos Jean-Claude EVP & Chief Operating Officer Other 3,636 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?